Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
3 NC counties are under alert, including Johnston County.
Program
On FOX50 at 10: Raleigh native & NBA coach is helping teen boys from single-parent households. His foundation & how he is working to bridge a gap
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Profound Medical Corp
(NQ:
PROF
)
9.030
-0.280 (-3.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
33,522
Open
9.350
Bid (Size)
3.690 (1)
Ask (Size)
12.15 (2)
Prev. Close
9.310
Today's Range
9.010 - 9.370
52wk Range
7.110 - 11.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Profound Medical Announces Second Quarter 2024 Financial Results
August 08, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Performance
YTD
+13.58%
+13.58%
1 Month
-17.08%
-17.08%
3 Month
+22.86%
+22.86%
6 Month
+9.32%
+9.32%
1 Year
+14.16%
+14.16%
More News
Read More
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
July 18, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
July 16, 2024
Via
Benzinga
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
July 11, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General Meeting of Shareholders Voting Results
May 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 14, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
May 06, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
April 22, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
Via
InvestorPlace
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering
January 04, 2024
Via
Investor Brand Network
Exposures
Product Safety
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
January 03, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday
December 28, 2023
Via
Benzinga
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.